S&P 500   4,274.04 (-0.72%)
DOW   33,980.32 (-0.50%)
QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.47%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
S&P 500   4,274.04 (-0.72%)
DOW   33,980.32 (-0.50%)
QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.47%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
S&P 500   4,274.04 (-0.72%)
DOW   33,980.32 (-0.50%)
QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.47%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
S&P 500   4,274.04 (-0.72%)
DOW   33,980.32 (-0.50%)
QQQ   328.49 (-1.14%)
AAPL   174.55 (+0.88%)
MSFT   291.32 (-0.47%)
META   174.85 (-2.57%)
GOOGL   119.55 (-1.77%)
AMZN   142.10 (-1.85%)
TSLA   911.99 (-0.84%)
NVDA   183.35 (-2.88%)
NIO   20.08 (-3.97%)
BABA   89.77 (-3.11%)
AMD   98.27 (-1.93%)
MU   61.62 (-3.51%)
T   18.42 (-0.81%)
CGC   4.06 (+7.41%)
F   16.03 (-2.43%)
GE   79.92 (-1.42%)
DIS   122.81 (-1.72%)
AMC   21.36 (-13.91%)
PYPL   99.42 (-2.61%)
PFE   49.27 (-1.18%)
NFLX   241.15 (-1.85%)
NYSE:ABC

AmerisourceBergen - ABC Stock Forecast, Price & News

$149.53
-3.13 (-2.05%)
(As of 08/17/2022 05:17 PM ET)
Add
Compare
Today's Range
$149.43
$153.35
50-Day Range
$139.00
$152.66
52-Week Range
$113.68
$167.19
Volume
852,651 shs
Average Volume
1.30 million shs
Market Capitalization
$31.32 billion
P/E Ratio
17.15
Dividend Yield
1.21%
Price Target
$173.45

AmerisourceBergen MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
16.0% Upside
$173.45 Price Target
Short Interest
Healthy
2.58% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.55
Upright™ Environmental Score
News Sentiment
0.03mentions of AmerisourceBergen in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$4.91 M Sold Last Quarter
Proj. Earnings Growth
4.82%
From $10.99 to $11.52 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.18 out of 5 stars

Medical Sector

12th out of 1,122 stocks

Drugs, Proprietaries, & Sundries Industry

1st out of 7 stocks

ABC stock logo

About AmerisourceBergen (NYSE:ABC) Stock

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Argus lifted their price objective on shares of AmerisourceBergen from $160.00 to $170.00 and gave the stock a "buy" rating in a research report on Wednesday, July 20th. Barclays upgraded shares of AmerisourceBergen from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $175.00 to $182.00 in a research note on Thursday, May 26th. Robert W. Baird boosted their target price on shares of AmerisourceBergen from $179.00 to $187.00 in a research note on Thursday, May 5th. StockNews.com raised shares of AmerisourceBergen from a "buy" rating to a "strong-buy" rating in a report on Tuesday, August 9th. Finally, Cowen reduced their price target on shares of AmerisourceBergen from $171.00 to $170.00 in a research report on Thursday, June 9th. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $173.45.

AmerisourceBergen Stock Performance

Shares of NYSE:ABC traded down $1.79 on Wednesday, hitting $150.87. The company's stock had a trading volume of 6,329 shares, compared to its average volume of 1,002,539. AmerisourceBergen has a 12 month low of $113.68 and a 12 month high of $167.19. The company has a market capitalization of $31.60 billion, a price-to-earnings ratio of 17.33, a price-to-earnings-growth ratio of 1.67 and a beta of 0.48. The stock's 50-day moving average is $143.43 and its two-hundred day moving average is $148.31. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.55 and a current ratio of 0.92.

AmerisourceBergen (NYSE:ABC - Get Rating) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $2.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.56 by $0.06. The company had revenue of $60.06 billion during the quarter, compared to analysts' expectations of $59.03 billion. AmerisourceBergen had a return on equity of 350.60% and a net margin of 0.78%. The company's revenue for the quarter was up 12.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.16 earnings per share. On average, equities research analysts forecast that AmerisourceBergen will post 10.99 EPS for the current year.

AmerisourceBergen Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 29th. Stockholders of record on Monday, August 15th will be issued a $0.46 dividend. The ex-dividend date is Friday, August 12th. This represents a $1.84 annualized dividend and a dividend yield of 1.22%. AmerisourceBergen's dividend payout ratio (DPR) is 21.10%.

Insider Activity

In other news, CEO Steven H. Collis sold 11,480 shares of the company's stock in a transaction on Tuesday, July 12th. The stock was sold at an average price of $142.35, for a total transaction of $1,634,178.00. Following the completion of the sale, the chief executive officer now directly owns 205,178 shares of the company's stock, valued at $29,207,088.30. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders sold a total of 34,440 shares of company stock worth $4,911,374 over the last 90 days. 28.80% of the stock is currently owned by company insiders.

Receive ABC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AmerisourceBergen and its competitors with MarketBeat's FREE daily newsletter.

ABC Stock News Headlines

27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
AmerisourceBergen (NYSE:ABC) PT Lowered to $175.00
AmerisourceBergen Boosts FY22 Outlook; Declares Dividend - Update
AmerisourceBergen Q3 Results Top Estimates
2 Growth Stocks Ready to Skyrocket Higher
See More Headlines
Receive ABC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AmerisourceBergen and its competitors with MarketBeat's FREE daily newsletter.

ABC Company Calendar

Ex-Dividend for 5/31 Dividend
5/13/2022
Dividend Payable
5/31/2022
Last Earnings
8/03/2022
Ex-Dividend for 8/29 Dividend
8/12/2022
Today
8/17/2022
Dividend Payable
8/29/2022
Fiscal Year End
9/30/2022
Next Earnings (Estimated)
11/03/2022

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
Sector
Medical
CUSIP
03073E10
Employees
42,000
Year Founded
2001

Price Target and Rating

Average Stock Price Forecast
$173.45
High Stock Price Forecast
$187.00
Low Stock Price Forecast
$162.00
Forecasted Upside/Downside
+16.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
9 Analysts

Profitability

Net Income
$1.54 billion
Pretax Margin
1.00%

Debt

Sales & Book Value

Annual Sales
$213.99 billion
Cash Flow
$11.65 per share
Book Value
$2.47 per share

Miscellaneous

Free Float
149,138,000
Market Cap
$31.32 billion
Optionable
Optionable
Beta
0.48

Social Links















ABC Stock - Frequently Asked Questions

Should I buy or sell AmerisourceBergen stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ABC shares.
View ABC analyst ratings
or view top-rated stocks.

What is AmerisourceBergen's stock price forecast for 2022?

9 brokerages have issued twelve-month price targets for AmerisourceBergen's shares. Their ABC share price forecasts range from $162.00 to $187.00. On average, they predict the company's share price to reach $173.45 in the next year. This suggests a possible upside of 13.6% from the stock's current price.
View analysts price targets for ABC
or view top-rated stocks among Wall Street analysts.

How have ABC shares performed in 2022?

AmerisourceBergen's stock was trading at $132.89 on January 1st, 2022. Since then, ABC stock has increased by 14.9% and is now trading at $152.66.
View the best growth stocks for 2022 here
.

When is AmerisourceBergen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our ABC earnings forecast
.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Co. (NYSE:ABC) issued its earnings results on Wednesday, August, 3rd. The company reported $2.62 earnings per share for the quarter, beating analysts' consensus estimates of $2.56 by $0.06. The firm earned $60.06 billion during the quarter, compared to analyst estimates of $59.03 billion. AmerisourceBergen had a trailing twelve-month return on equity of 350.60% and a net margin of 0.78%. The firm's revenue was up 12.5% on a year-over-year basis. During the same period in the prior year, the firm earned $2.16 EPS.
Read the conference call transcript
.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen announced a quarterly dividend on Wednesday, August 3rd. Shareholders of record on Monday, August 15th will be paid a dividend of $0.46 per share on Monday, August 29th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 1.21%. The ex-dividend date of this dividend is Friday, August 12th.
Read our dividend analysis for ABC
.

Is AmerisourceBergen a good dividend stock?

AmerisourceBergen (NYSE:ABC) pays an annual dividend of $1.84 per share and currently has a dividend yield of 1.22%. The company has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 21.10%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ABC will have a dividend payout ratio of 15.97% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ABC.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen issued an update on its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided EPS guidance of $10.90-$11.10 for the period, compared to the consensus estimate of $10.93. The company issued revenue guidance of -.

What is Steve Collis' approval rating as AmerisourceBergen's CEO?

447 employees have rated AmerisourceBergen Chief Executive Officer Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among the company's employees.

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Pfizer (PFE).

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by many different institutional and retail investors. Top institutional shareholders include JPMorgan Chase & Co. (3.59%), State Street Corp (3.26%), FMR LLC (2.70%), Northern Trust Corp (0.92%), Wells Fargo & Company MN (0.80%) and Coho Partners Ltd. (0.74%). Insiders that own company stock include Dermot Mark Durcan, Elizabeth S Campbell, Gina Clark, Henry Wadsworth Mcgee III, Jane E Md Henney, John G Chou, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Robert P Mauch, Silvana Battaglia, Steven H Collis and Walgreens Boots Alliance, Inc.
View institutional ownership trends
.

How do I buy shares of AmerisourceBergen?

Shares of ABC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $152.66.

How much money does AmerisourceBergen make?

AmerisourceBergen (NYSE:ABC) has a market capitalization of $31.98 billion and generates $213.99 billion in revenue each year. The company earns $1.54 billion in net income (profit) each year or $8.72 on an earnings per share basis.

How many employees does AmerisourceBergen have?

The company employs 42,000 workers across the globe.

Does AmerisourceBergen have any subsidiaries?
The following companies are subsidiares of AmerisourceBergen: AB Singapore Investments Pte Ltd, AB UK Holdings Ltd, ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group GmbH, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Sourcing LLC, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Physician Networks L.L.C., IntrinsiQ, Lash Group, MWI Veterinary Supply, Network for Medical Communications & Research, PMSI, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, Wight Nederland Holdco 2 BV, World Courier, World Courier Group S.à r.l., and Xcenda.
Read More
When was AmerisourceBergen founded?

AmerisourceBergen was founded in 2001.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The official website for the company is www.amerisourcebergen.com. The company can be reached via phone at (610) 727-7000, via email at investorrelations@amerisourcebergen.com, or via fax at 800-640-5221.

This page (NYSE:ABC) was last updated on 8/17/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.